The role of cell death in the pathogenesis of autoimmune disease: HMGB1 and microparticles as intercellular mediators of inflammation

[1]  Herbert J. Zeh,et al.  Masquerader: High Mobility Group Box-1 and Cancer , 2007, Clinical Cancer Research.

[2]  A. Piccin,et al.  Circulating microparticles: pathophysiology and clinical implications. , 2007, Blood reviews.

[3]  I. Maruyama,et al.  Increased serum high mobility group box‐1 level in Churg–Strauss syndrome
THIS ARTICLE HAS BEEN RETRACTED , 2007, Clinical and experimental immunology.

[4]  L. Audoly,et al.  Toll-like receptor 9–dependent activation by DNA-containing immune complexes is mediated by HMGB1 and RAGE , 2007, Nature Immunology.

[5]  P. Gregersen,et al.  Cholinergic Anti-Inflammatory Pathway Activity and High Mobility Group Box-1 (HMGB1) Serum Levels in Patients with Rheumatoid Arthritis , 2007, Molecular medicine.

[6]  K. Tracey,et al.  High mobility group box‐1 protein induces the migration and activation of human dendritic cells and acts as an alarmin , 2007, Journal of leukocyte biology.

[7]  Jeon-Soo Shin,et al.  Nucleocytoplasmic Shuttling of HMGB1 Is Regulated by Phosphorylation That Redirects It toward Secretion1 , 2006, The Journal of Immunology.

[8]  D. Pisetsky,et al.  The extracellular release of HMGB1 during apoptotic cell death. , 2006, American journal of physiology. Cell physiology.

[9]  M. Ratajczak,et al.  Enhancing effect of platelet‐derived microvesicles on the invasive potential of breast cancer cells , 2006, Transfusion.

[10]  H. Harris,et al.  Increased extracellular levels of the novel proinflammatory cytokine high mobility group box chromosomal protein 1 in minor salivary glands of patients with Sjögren's syndrome. , 2006, Arthritis and rheumatism.

[11]  E. Abraham,et al.  High mobility group box 1 protein interacts with multiple Toll-like receptors. , 2006, American journal of physiology. Cell physiology.

[12]  C. Sáez,et al.  Circulating platelet-derived microparticles in systemic lupus erythematosus , 2005, Thrombosis and Haemostasis.

[13]  L. Padyukov,et al.  Increased expression of the novel proinflammatory cytokine high mobility group box chromosomal protein 1 in skin lesions of patients with lupus erythematosus. , 2005, Arthritis and rheumatism.

[14]  D. Pisetsky,et al.  Microparticles as regulators of inflammation: novel players of cellular crosstalk in the rheumatic diseases. , 2005, Arthritis and rheumatism.

[15]  D. Stern,et al.  Understanding RAGE, the receptor for advanced glycation end products , 2005, Journal of Molecular Medicine.

[16]  S. Gay,et al.  The release of microparticles by apoptotic cells and their effects on macrophages , 2005, Apoptosis.

[17]  L. Horstman,et al.  Elevation of endothelial microparticles, platelets, and leukocyte activation in patients with venous thromboembolism. , 2005, Journal of the American College of Cardiology.

[18]  R. Andriantsitohaina,et al.  Shed membrane microparticles from circulating and vascular cells in regulating vascular function. , 2005, American journal of physiology. Heart and circulatory physiology.

[19]  D. Pisetsky,et al.  The induction of matrix metalloproteinase and cytokine expression in synovial fibroblasts stimulated with immune cell microparticles. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[20]  U. Andersson,et al.  RAGE is the Major Receptor for the Proinflammatory Activity of HMGB1 in Rodent Macrophages , 2005, Scandinavian journal of immunology.

[21]  Masaki Tanaka,et al.  Contributions of high mobility group box protein in experimental and clinical acute lung injury. , 2004, American journal of respiratory and critical care medicine.

[22]  J. Palmblad,et al.  Activation of Human Umbilical Vein Endothelial Cells Leads to Relocation and Release of High‐Mobility Group Box Chromosomal Protein 1 , 2004, Scandinavian journal of immunology.

[23]  F. Scheiflinger,et al.  Native Versus Recombinant High-Mobility Group B1 Proteins: Functional Activity In Vitro , 2004, Inflammation.

[24]  K. Tracey,et al.  High Mobility Group Box Protein 1: An Endogenous Signal for Dendritic Cell Maturation and Th1 Polarization , 2004, The Journal of Immunology.

[25]  N. Young,et al.  Elevated circulating endothelial membrane microparticles in paroxysmal nocturnal haemoglobinuria , 2004, British journal of haematology.

[26]  D. Mant,et al.  Endothelial and platelet microparticles in vasculitis of the young. , 2004, Arthritis and rheumatism.

[27]  S. Müller,et al.  Regulated expression and subcellular localization of HMGB1, a chromatin protein with a cytokine function , 2004, Journal of internal medicine.

[28]  E. Abraham,et al.  Involvement of Toll-like Receptors 2 and 4 in Cellular Activation by High Mobility Group Box 1 Protein* , 2004, Journal of Biological Chemistry.

[29]  R. Hebbel,et al.  Sickle blood contains tissue factor-positive microparticles derived from endothelial cells and monocytes. , 2003, Blood.

[30]  J. Palmblad,et al.  High mobility group 1 B‐box mediates activation of human endothelium , 2003, Journal of internal medicine.

[31]  H. Harris,et al.  Successful treatment of collagen-induced arthritis in mice and rats by targeting extracellular high mobility group box chromosomal protein 1 activity. , 2003, Arthritis and rheumatism.

[32]  U. Andersson,et al.  High mobility group box chromosomal protein 1, a DNA binding cytokine, induces arthritis. , 2003, Arthritis and rheumatism.

[33]  L. Horstman,et al.  High levels of circulating endothelial microparticles in patients with acute coronary syndromes. , 2003, American heart journal.

[34]  M. Yamakuchi,et al.  High mobility group box chromosomal protein 1 plays a role in the pathogenesis of rheumatoid arthritis as a novel cytokine. , 2003, Arthritis and rheumatism.

[35]  S. Müller,et al.  HMGB1 interacts differentially with members of the Rel family of transcription factors. , 2003, Biochemical and Biophysical Research Communications - BBRC.

[36]  Angelika Pedal,et al.  Release and Intercellular Transfer of Cell Surface CD81 Via Microparticles1 , 2002, The Journal of Immunology.

[37]  F. Breedveld,et al.  Cell-derived microparticles in synovial fluid from inflamed arthritic joints support coagulation exclusively via a factor VII-dependent mechanism. , 2002, Arthritis and rheumatism.

[38]  M. Bianchi,et al.  The nuclear protein HMGB1 is secreted by monocytes via a non‐classical, vesicle‐mediated secretory pathway , 2002, EMBO reports.

[39]  Jun Yu Li,et al.  High mobility group box chromosomal protein 1: a novel proinflammatory mediator in synovitis. , 2002, Arthritis and rheumatism.

[40]  T. Misteli,et al.  Release of chromatin protein HMGB1 by necrotic cells triggers inflammation , 2002, Nature.

[41]  M. A. van de Laar,et al.  Elevated levels of platelet microparticles are associated with disease activity in rheumatoid arthritis. , 2002, Arthritis and rheumatism.

[42]  D. Praticò,et al.  Platelet-derived microparticles stimulate proliferation, survival, adhesion, and chemotaxis of hematopoietic cells. , 2002, Experimental hematology.

[43]  D. Isenberg,et al.  Increased circulating platelet–leucocyte complexes and platelet activation in patients with antiphospholipid syndrome, systemic lupus erythematosus and rheumatoid arthritis , 2001, British journal of haematology.

[44]  R. North,et al.  Rapid secretion of interleukin-1β by microvesicle shedding , 2001 .

[45]  A. Minagar,et al.  Elevated plasma endothelial microparticles in multiple sclerosis , 2001, Neurology.

[46]  S. Müller,et al.  The High Mobility Group (Hmg) Boxes of the Nuclear Protein Hmg1 Induce Chemotaxis and Cytoskeleton Reorganization in Rat Smooth Muscle Cells , 2001, The Journal of cell biology.

[47]  L. Vallar,et al.  β2-glycoprotein I Binding to Platelet Microparticle Membrane Specifically Reduces Immunoreactivity of Glycoproteins IIb/IIIa , 2001, Thrombosis and Haemostasis.

[48]  L. Horstman,et al.  Elevated endothelial microparticles in thrombotic thrombocytopenic purpura: findings from brain and renal microvascular cell culture and patients with active disease , 2001, British journal of haematology.

[49]  H. Messmore,et al.  Mechanisms of Venous and Arterial Thrombosis in Heparin-Induced Thrombocytopenia , 2000, Journal of Thrombosis and Thrombolysis.

[50]  A. Michelson,et al.  Platelet and Platelet-derived Microparticle Surface Factor V/Va Binding in Whole Blood: Differences between Neonates and Adults , 2000, Thrombosis and Haemostasis.

[51]  A. Rosenberg,et al.  Relationship between sex and antibodies to high mobility group proteins 1 and 2 in juvenile idiopathic arthritis. , 2000, The Journal of rheumatology.

[52]  K. Tracey,et al.  High Mobility Group 1 Protein (Hmg-1) Stimulates Proinflammatory Cytokine Synthesis in Human Monocytes , 2000, The Journal of experimental medicine.

[53]  K. Chorneyko,et al.  Morphological analysis of microparticle generation in heparin-induced thrombocytopenia. , 2000, Blood.

[54]  H. Brühl,et al.  Transfer of the chemokine receptor CCR5 between cells by membrane-derived microparticles: A mechanism for cellular human immunodeficiency virus 1 infection , 2000, Nature Medicine.

[55]  T. Kislinger,et al.  Blockade of RAGE–amphoterin signalling suppresses tumour growth and metastases , 2000, Nature.

[56]  M. U. Nollert,et al.  Leukocyte-leukocyte interactions mediated by platelet microparticles under flow. , 2000, Blood.

[57]  R. Westendorp,et al.  Cellular origin and procoagulant properties of microparticles in meningococcal sepsis. , 2000, Blood.

[58]  K. Tracey,et al.  Proinflammatory cytokines (tumor necrosis factor and interleukin 1) stimulate release of high mobility group protein-1 by pituicytes. , 1999, Surgery.

[59]  K. Tracey,et al.  HMG-1 as a late mediator of endotoxin lethality in mice. , 1999, Science.

[60]  A. Aguzzi,et al.  The lack of chromosomal protein Hmg1 does not disrupt cell growth but causes lethal hypoglycaemia in newborn mice , 1999, Nature Genetics.

[61]  L. Horstman,et al.  Platelet microparticles: a wide-angle perspective. , 1999, Critical reviews in oncology/hematology.

[62]  J. Freyssinet,et al.  Shed membrane microparticles with procoagulant potential in human atherosclerotic plaques: a role for apoptosis in plaque thrombogenicity. , 1999, Circulation.

[63]  D. Edwards,et al.  High-Mobility Group Chromatin Proteins 1 and 2 Functionally Interact with Steroid Hormone Receptors To Enhance Their DNA Binding In Vitro and Transcriptional Activity in Mammalian Cells , 1998, Molecular and Cellular Biology.

[64]  G. FitzGerald,et al.  Modulation of monocyte-endothelial cell interactions by platelet microparticles. , 1998, The Journal of clinical investigation.

[65]  C. Prives,et al.  High mobility group protein-1 (HMG-1) is a unique activator of p53. , 1998, Genes & development.

[66]  Shirakawa,et al.  Prevalence and characterization of perinuclear anti‐neutrophil cytoplasmic antibodies (P‐ANCA) directed against HMG1 and HMG2 in ulcerative colitis (UC) , 1998, Clinical and experimental immunology.

[67]  K. Maquelin,et al.  Cell-derived microparticles generated in patients during cardiopulmonary bypass are highly procoagulant. , 1997, Circulation.

[68]  G. FitzGerald,et al.  Transcellular activation of platelets and endothelial cells by bioactive lipids in platelet microparticles. , 1997, The Journal of clinical investigation.

[69]  G. Längst,et al.  High Mobility Group 1 Protein Is Not Stably Associated with the Chromosomes of Somatic Cells , 1997, The Journal of cell biology.

[70]  S. Rajagopalan,et al.  Structure and specificity of T cell receptors expressed by potentially pathogenic anti-DNA autoantibody-inducing T cells in human lupus. , 1995, The Journal of clinical investigation.

[71]  D. Monroe,et al.  Coagulation Factor IXa Binding to Activated Platelets and Platelet-Derived Microparticles: A Flow Cytometric Study , 1992, Thrombosis and Haemostasis.

[72]  D. Lilley,et al.  The DNA binding site of HMG1 protein is composed of two similar segments (HMG boxes), both of which have counterparts in other eukaryotic regulatory proteins. , 1992, The EMBO journal.

[73]  B. Furie,et al.  Platelet-derived microparticles express high affinity receptors for factor VIII. , 1991, The Journal of biological chemistry.

[74]  M. Daston,et al.  Expression of P30, a protein with adhesive properties, in Schwann cells and neurons of the developing and regenerating peripheral nerve , 1991, The Journal of cell biology.

[75]  H. Truckenbrodt,et al.  Autoantibodies to nonhistone chromosomal proteins HMG-1 and HMG-2 in sera of patients with juvenile rheumatoid arthritis. , 1990, Arthritis and rheumatism.

[76]  C. Esmon,et al.  Assembly of the platelet prothrombinase complex is linked to vesiculation of the platelet plasma membrane. Studies in Scott syndrome: an isolated defect in platelet procoagulant activity. , 1989, The Journal of biological chemistry.

[77]  P. Bütikofer,et al.  Enrichment of two glycosyl-phosphatidylinositol-anchored proteins, acetylcholinesterase and decay accelerating factor, in vesicles released from human red blood cells. , 1989, Blood.

[78]  G. Reeck,et al.  A human placental cDNA clone that encodes nonhistone chromosomal protein HMG-1. , 1989, Nucleic acids research.

[79]  P. Wolf.  The Nature and Significance of Platelet Products in Human Plasma , 1967, British journal of haematology.

[80]  L. Horstman,et al.  Platelet activation rather than endothelial injury identifies risk of thrombosis in subjects positive for antiphospholipid antibodies. , 2007, Thrombosis research.

[81]  F. Dignat-George,et al.  Endothelial microparticles: a potential contribution to the thrombotic complications of the antiphospholipid syndrome , 2004, Thrombosis and Haemostasis.

[82]  G. Migliaretti,et al.  High prevalence of autoantibodies against the nuclear high mobility group (HMG) protein SSRP1 in sera from patients with systemic lupus erythematosus, but not other rheumatic diseases. , 2002, The Journal of rheumatology.